Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth. Schizophrenia is a mental illness with a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (false beliefs).
Therapeutic Indication
### Therapeutic indication Maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
Therapeutic Area (MeSH)
N/AATC Code
N05AX12
ATC Item
aripiprazole
Pharmacotherapeutic Group
Psycholeptics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| aripiprazole | N/A | 阿立哌唑 |
EMA Name
Abilify Maintena
Medicine Name
Abilify Maintena
Aliases
N/ANo risk management plan link.
